CTAS vs IXHL · P/E 51, rev $11.26B vs rev $86.0K
Cintas Corporation (CTAS) versus Incannex Healthcare Ltd ADR (IXHL) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Incannex Healthcare Ltd ADR (IXHL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported IXHL revenue for 2025-06-30 was $86.0K. Net income was -$46.9M. Revenue was up 616.7% from 2024-06-30 to 2025-06-30. IXHL currently screens at market cap $44.3M.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. IXHL currently screens at market cap $44.3M.
Not investment advice. Open the CTAS and IXHL stock pages for the full models.
Not investment advice.